Doheny Asset Management /Ca Eiger Bio Pharmaceuticals, Inc. Transaction History

Doheny Asset Management /Ca

  • $146 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$0.0 - $13.1 $0 - $279,030
21,300 New
21,300 $269,000
Q3 2020

Nov 12, 2020
SELL
$7.96 - $12.42 $358,836 - $559,893
-45,080 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$7.96 - $12.42 $189,288 - $295,347
23,780 Added 111.64%
45,080 $367,000
Q2 2020

Aug 18, 2020
BUY
$5.4 - $13.37 $115,020 - $284,781
21,300 New
21,300 $204,000

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $418M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Doheny Asset Management /Ca Portfolio

Follow Doheny Asset Management /Ca and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

News

Stay updated on Doheny Asset Management /Ca with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email